News

This story was originally published on RNZ Politicians heard emotional pleas today from cancer survivors, people with disabilities and health...

Dr Ken Romeril, chief executive, Myeloma New Zealand, is appearing today before the Health Select Committee in support of their submission asking...

Omar Nadeem, MD, a physician at Dana-Farber Cancer Institute and an instructor in medicine at Harvard Medical School, discusses individualizing...

This story was originally published on the Hematology Advisor The introduction of monoclonal antibodies and immunomodulators into earlier lines of...

A new drug reduced the risk of relapse and increased survival by five months, according to a recent study. The results were presented at a cancer...

In the past 20 years, we’ve been very fortunate in the development of effective myeloma therapies and have seen remarkable progress for our...

For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and dexamethasone is associated with a reduced risk...

Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders fundraise, petition and apply for...

Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder and is described as an intermediate stage between monoclonal...

Lenalidomide (Revlimid) significantly reduced the risk for smoldering multiple myeloma to progress to cancer among patients with moderate to high...

“More protest action is on the cards if this government isn’t prepared to give Pharmac more money “, said mother of three Joy Wilkie of Ngati...